1 |
Magliano DJ, Boyko EJ. IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas:10th ed[R/OL].Brussels: International Diabetes Federation, 2021.
URL
|
2 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 国际内分泌代谢杂志, 2021, 41(5): 482-548.
|
3 |
李永涛, 姜杨, 张善强, et al. 间充质干细胞对糖尿病及其并发症的治疗应用现状 [J]. 齐齐哈尔医学院学报, 2020, 41(7): 886-887.
|
4 |
Zang L, Li Y, Hao H, et al. Efficacy of umbilical cord-derived mesenchymal stem cells in the treatment of type 2 diabetes assessed by retrospective continuous glucose monitoring [J]. Stem Cells Translational Medicine, 2023, 12(12):775-782.
|
5 |
杜婧, 魏翠英. 间充质干细胞治疗2型糖尿病及其相关并发症的可能机制研究进展 [J]. 山东医药, 2021, 61(22): 84-87.
|
6 |
Mathur A, Taurin S, Alshammary S. The safety and efficacy of mesenchymal stem cells in the treatment of type 2 Diabetes-A literature review [J]. Diabetes Metab Syndr Obes, 2023, 16:769-777.
|
7 |
Wu Z, Cai J, Chen J, et al. Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial [J]. Cytotherapy, 2014, 16(2): 258-265.
|
8 |
Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation [J]. Stem Cell Res Ther, 2020, 11(1): 97.
|
9 |
Chen J, Ye Y, Liao L, et al. Mesenchymal stem cells promote islet survival in vitro and function in vivo. [J]. CellR4, 2013, 1(2): 128-136.
|
10 |
Campbell JE, Newgard CB. Mechanisms controlling pancreatic islet cell function in insulin secretion[J]. Nature reviews Molecular cell biology, 2021, 22(2):142-158.
|
11 |
Lansberry T, Stabler C. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery [J]. Advanced Drug Delivery Reviews, 2024, 115179. doi: 10.1016/j.addr.2024.115179.
|
12 |
Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells[J]. Am J Ther, 2005, 12(6): 580-591.
|
13 |
Sato Y, Endo H, Okuyama H, et al. Cellular hypoxia of pancreatic beta-cells due to high levels of oxygen consumption for insulin secretion in vitro[J]. J Biol Chem, 2011, 286(14): 12524-12532.
|
14 |
Barbu A, Jansson L, Sandberg M, et al. The use of hydrogen gas clearance for blood flow measurements in single endogenous and transplanted pancreatic islets [J]. Microvasc Res, 2015, 97:124-129.
|
15 |
Ilegems E, Bryzgalova G, Correia J, et al. Share HIF-1α inhibitor PX-478 preserves pancreatic β cell function in diabetes[J]. Sci Transl Med, 2022, 14(638):eaba9112.
|
16 |
Chen Y, He Y, Zhou H. The potential role of lncRNAs in diabetes and diabetic microvascular complications[J]. Endocr J, 2020, 67(7): 659-668.
|
17 |
Dieter C, Lemos NE, Corrêa NRF, et al. The impact of lncRNAs in diabetes mellitus: a systematic review and in silico analyses[J]. Front Endocrinol (Lausanne), 2021, 12:602597.doi: 10.3389/fendo.2021.602597.eCollection 2021.
|
18 |
陈俊秋, 陈津, 黄梁浒, 等. 间充质细胞外泌体促进小鼠胰岛内皮细胞血管生成的研究 [J/OL]. 中华细胞与干细胞杂志(电子版), 2018, 8(4): 212-217.
|
19 |
Madani S, Amanzadi M, Aghayan HR, et al. Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis [J]. Syst Rev, 2022, 11(1): 82. doi: 10.1186/s13643-022-01950-3.
|
20 |
Zhang J, Zheng Y, Huang L, et al. Research progress on mesenchymal stem cells for the treatment of diabetes and its complications[J]. Int J Endocrinol, 2023, 2023:9324270. doi: 10.1155/2023/9324270.eCollection 2023.
|
21 |
Xiong J, Hu H, Guo R, et al. Mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications[J]. Front Endocrinol (Lausanne). 2021, 12:646233. doi: 10.3389/fendo.2021.646233.eCollection 2021.
|
22 |
Xu YX, Pu SD, Li X, et al. Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications [J]. Pharmacol Res, 2022, 178:106135. doi: 10.1016/j.phrs.2022.106135.
|
23 |
苗海霞, 李冬梅, 郑雁红, et al. 长链非编码RNA在糖尿病中的研究进展 [J]. 内蒙古医学杂志, 2019, 51(8): 933-935.
|
24 |
Yuan X, Wang J, Tang X, et al. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles[J]. J Transl Med, 2015, 13:24. doi: 10.1186/s12967-015-0383-6.
|
25 |
Yang QQ, Deng YF. Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray [J]. Histopathology, 2015, 66(7):1022-1030.
|
26 |
Zou Y, Li C, Shu F, et al. lncRNA expression signatures in periodontitis revealed by microarray: the potential role of lncRNAs in periodontitis pathogenesis [J]. Journal of cellular biochemistry, 2015, 116(4):640-647.
|
27 |
Sumara G, Formentini I, Collins S, et al. Regulation of PKD by the MAPK p38δ in insulin secretion and glucose homeostasis[J]. Cell, 2009, 136(2): 235-248.
|
28 |
张丹, 王海杰. 缺血缺氧状态下细胞自噬的研究进展 [J]. 国际病理科学与临床杂志, 2009, 29(4): 293-297.
|
29 |
Noguchi M, Hirata N, Tanaka T, et al. Autophagy as a modulator of cell death machinery[J]. Cell Death Dis, 2020, 11(7):517. doi: 10.1038/s41419-020-2724-5.
|